Clinical Data Supporting Pneumococcal Vaccination
August 23rd 2024Key opinion leaders examine the pivotal clinical data that supported the FDA approvals of PCV15, PCV20, and PCV21, while also explaining the differences between polysaccharide and conjugate pneumococcal vaccines in terms of their induced immune responses and the durability of protection they offer.
Clinical Considerations for Pneumococcal Vaccination Scheduling
August 23rd 2024The medical experts explore the importance of receiving PCV20 following PCV13 and PPSV23 vaccinations, while also delving into the broader discussion of how sequential administration of these pneumococcal vaccines may potentially enhance protection against targeted strains.
Target Patient Populations for Pneumococcal Vaccines
August 16th 2024Krista D. Capehart, PharmD, BCACP, FAPhA, Dr. Capeheart outlines the patient populations for whom pneumococcal vaccines are indicated and provides a detailed explanation of the ACIP-recommended immunization schedules for these vaccines.
Empowering Pharmacists: Navigating Pediatric OTC Medications and Building Trust With Parents
August 16th 2024Key opinion leaders provide pharmacists with essential guidance on the appropriate dosing and administration of over-the-counter medications for common pediatric conditions, while equipping them with strategies to effectively counsel parents on symptom identification, condition management, and when to seek medical advice for children's health issues.
Analysis: What to Expect From CMS' Inflation Reduction Act Drug Pricing Announcement
August 16th 2024A federal and state policy expert discusses the announcement from the Centers for Medicare & Medicaid Services on the agreement to lower prices for 10 selected drugs due to the Inflation Reduction Act.
Comparing and Contrasting the Characteristics of the FDA-Approved Pneumococcal Vaccines
August 9th 2024The pneumococcal vaccination experts offer a comparative analysis of the five FDA-approved pneumococcal vaccines, focusing on their structural differences and the specific strains each vaccine targets.
Vaccination Efforts to Mitigate Pneumococcal Outbreaks
August 9th 2024The panel of healthcare professionals examines how strategic vaccination can effectively mitigate pneumococcal outbreaks, thereby reducing exposure risks to vulnerable populations in healthcare settings such as nursing homes and hospitals.